The Pharmacokinetics of GLA5PR Tablet According to the Renal Function
NCT03963362
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuropathic Pain
Interventions
DRUG:
GLA5PR tablet 75 mg
DRUG:
GLA5PR tablet 150 mg
Sponsor
GL Pharm Tech Corporation